Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

329
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
329
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Innate Immunity to Cancer Therapy: Antimicrobial Peptides as Emerging Anticancer Agents.

International journal of molecular sciences·2026
Same author

Ranolazine Co-Crystal: Molecular Docking, Coformer Selection, In vitro, In vivo Pharmacokinetic Assesment in Rat Plasma.

Current topics in medicinal chemistry·2026
Same author

Synthetic Imidazole Derivatives as Multitarget Agents in Depression: Insights into Mechanism and Therapeutic Promise.

CNS & neurological disorders drug targets·2026
Same author

Antimicrobial Consumption and Resistance Dynamics Across Healthcare Level: Global Evidence and Stewardship Implications.

Pathogens (Basel, Switzerland)·2026
Same author

From Mechanisms to Medicine: Astrocyte Dysfunction in Stress-Related Neuroinflammation and Alzheimer's Disease.

The European journal of neuroscience·2026
Same author

Neuropeptide Y Receptor Modulators in Gut Physiology and Therapy.

Current protein & peptide science·2026

Related Experiment Video

Updated: Sep 17, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.6K

Promising Flavone Derivatives as Anticancer Agents.

Vishakha A Patil1, Kalyani R Thombre1, Krishna Radheshyam Gupta1

  • 1Department of Pharmaceutical Chemistry, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, India.

Medicinal Chemistry (Shariqah (United Arab Emirates))
|July 4, 2025
PubMed
Summary
This summary is machine-generated.

Flavones, natural compounds from plants, show significant anticancer properties by targeting key cancer pathways. Structural modifications enhance their potency and selectivity for developing novel, effective cancer drugs.

Keywords:
Flavoneanticancer activityderivatives.flavone analogues

More Related Videos

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

9.4K
Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

456

Related Experiment Videos

Last Updated: Sep 17, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.6K
Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

9.4K
Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

456

Area of Science:

  • Natural Products Chemistry
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Flavonoids, particularly flavones, are natural compounds found in fruits, vegetables, and medicinal plants.
  • These compounds exhibit diverse biological activities, including anti-inflammatory, antioxidant, and potent anticancer properties.
  • Flavones are recognized for their ability to modulate critical molecular pathways involved in cancer progression, such as cell growth, apoptosis, angiogenesis, and metastasis.

Purpose of the Study:

  • To provide a comprehensive review of the chemical structure of flavones as anticancer agents.
  • To explore the potential for structural modification of the flavone scaffold to enhance therapeutic efficacy.
  • To highlight structural alterations in flavone derivatives that improve anticancer potency and selectivity.

Main Methods:

  • Literature review and analysis of existing research on flavones and their derivatives.
  • Examination of structure-activity relationships (SAR) of flavone compounds.
  • Synthesis and evaluation of modified flavone structures for anticancer activity.

Main Results:

  • Flavones possess inherent anticancer properties by interfering with cancer cell proliferation and survival mechanisms.
  • Structural modifications of the flavone backbone can significantly enhance anticancer potency and selectivity.
  • Specific derivatives show promise in targeting key oncogenic pathways, leading to improved therapeutic outcomes.

Conclusions:

  • Flavones represent a promising scaffold for the development of novel anticancer therapeutics.
  • Further research into flavone derivatives could lead to the creation of more effective and targeted cancer treatments.
  • Optimizing flavone structures offers a viable strategy for overcoming limitations of current anticancer therapies.